ATNX - Spark Newswire

1 minute read

Athenex Announces Results Of Special Meeting; Shareholders Voted In Favor Of All 3 Proposals. Increase The Total Amount Of Shares; Authorize A Reverse Stock Split To Regain Compliance With Nasdaq; Increase The Number Of Shares Available For The Co’s 20…

By Benzinga Newsdesk

November 22, 11:35 AM

Shareholders voted in favor of all three proposals submitted before the Special Stockholder Meeting

ATNX

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

November 7, 8:37 AM

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.

ATNX

1 minute read

News

Athenex Announces Receipt Of Positive Nasdaq Listing Determination

By Benzinga Newsdesk

November 3, 7:21 AM

Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that

ATNX